Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.870
+0.070 (2.50%)
May 13, 2025, 12:45 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 914.33 million as of May 13, 2025. Its market cap has decreased by -78.72% in one year.
Market Cap
914.33M
Enterprise Value
-357.63M
Revenue
104.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.87
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 914.33M, a decrease of -83.45%. That is a compound annual growth rate of -28.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 898.66M | -9.65% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.57B |
| Nordhealth AS | 2.80B |
| Photocure ASA | 1.33B |
| Vistin Pharma ASA | 1.09B |
| Hofseth BioCare ASA | 871.49M |
| Omda AS | 849.02M |
| Gentian Diagnostics ASA | 848.23M |
| ArcticZymes Technologies ASA | 832.46M |